(Rac)-Norepinephrine-d3 (formate)

CAT:
804-HY-13715S-01
Size:
1 mg
  • Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
  • Dry Ice Shipment: No
(Rac)-Norepinephrine-d3 (formate) - image 1

(Rac)-Norepinephrine-d3 (formate)

  • UNSPSC Description:

    (Rac)-Norepinephrine-d3 (formate) is deuterium labeled Norepinephrine. Norepinephrine (Levarterenol; L-Noradrenaline) is a potent adrenergic receptor (AR) agonist. Norepinephrine activates α1, α2, β1 receptors[1][2][3][4].
  • Target Antigen:

    Adrenergic Receptor; Autophagy; Endogenous Metabolite; Isotope-Labeled Compounds
  • Type:

    Isotope-Labeled Compounds
  • Related Pathways:

    Autophagy;GPCR/G Protein;Metabolic Enzyme/Protease;Neuronal Signaling;Others
  • Field of Research:

    Endocrinology; Cardiovascular Disease
  • Smiles:

    NC([2H])([2H])C(C1=CC(O)=C(C=C1)O)([2H])O.[H]C(O)=O
  • Molecular Weight:

    218.22
  • References & Citations:

    [1]Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019;53(2):211-216.|[2]Brian P Ramos, et al. Adrenergic pharmacology and cognition: focus on the prefrontal cortex. Pharmacol Ther. 2007 Mar;113(3):523-36.|[3]Littlejohn NK, et al. Suppression of Resting Metabolism by the Angiotensin AT2 Receptor. Cell Rep. 2016 Aug 9;16(6):1548-60.|[4]MacGregor DA, et al. Relative efficacy and potency of beta-adrenoceptor agonists for generating cAMP in human lymphocytes. Chest. 1996 Jan;109(1):194-200.|[5]Xinyu Xu, et al. Binding pathway determines norepinephrine selectivity for the human β 1 AR over β 2 AR. Cell Res. 2021 May;31(5):569-579.
  • Shipping Conditions:

    Room temperature